1. Home
  2. GDDY vs UTHR Comparison

GDDY vs UTHR Comparison

Compare GDDY & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDDY
  • UTHR
  • Stock Information
  • Founded
  • GDDY 1997
  • UTHR 1996
  • Country
  • GDDY United States
  • UTHR United States
  • Employees
  • GDDY N/A
  • UTHR N/A
  • Industry
  • GDDY EDP Services
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDDY Technology
  • UTHR Health Care
  • Exchange
  • GDDY Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • GDDY 20.0B
  • UTHR 20.7B
  • IPO Year
  • GDDY 2015
  • UTHR 1999
  • Fundamental
  • Price
  • GDDY $133.78
  • UTHR $448.47
  • Analyst Decision
  • GDDY Buy
  • UTHR Buy
  • Analyst Count
  • GDDY 13
  • UTHR 15
  • Target Price
  • GDDY $202.31
  • UTHR $459.60
  • AVG Volume (30 Days)
  • GDDY 1.5M
  • UTHR 846.4K
  • Earning Date
  • GDDY 10-30-2025
  • UTHR 10-29-2025
  • Dividend Yield
  • GDDY N/A
  • UTHR N/A
  • EPS Growth
  • GDDY N/A
  • UTHR 17.94
  • EPS
  • GDDY 5.60
  • UTHR 25.63
  • Revenue
  • GDDY $4,752,100,000.00
  • UTHR $3,077,800,000.00
  • Revenue This Year
  • GDDY $9.75
  • UTHR $13.71
  • Revenue Next Year
  • GDDY $7.21
  • UTHR $5.72
  • P/E Ratio
  • GDDY $23.90
  • UTHR $17.38
  • Revenue Growth
  • GDDY 7.93
  • UTHR 17.62
  • 52 Week Low
  • GDDY $131.29
  • UTHR $266.98
  • 52 Week High
  • GDDY $216.00
  • UTHR $459.48
  • Technical
  • Relative Strength Index (RSI)
  • GDDY 34.13
  • UTHR 65.25
  • Support Level
  • GDDY $133.50
  • UTHR $415.00
  • Resistance Level
  • GDDY $139.44
  • UTHR $459.40
  • Average True Range (ATR)
  • GDDY 3.48
  • UTHR 13.47
  • MACD
  • GDDY -0.25
  • UTHR -1.34
  • Stochastic Oscillator
  • GDDY 14.85
  • UTHR 71.49

About GDDY GoDaddy Inc.

GoDaddy provides domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: